Checkpoint Therapeutics (NASDAQ:CKPT) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Checkpoint Therapeutics (CKPT) operate in?

Checkpoint Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Checkpoint Therapeutics Stock (NASDAQ: CKPT) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	7.09K / 1.30M
Day Range	- - -
52 Wk Range	1.38 - 4.50
Market Cap	$177.26M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	14.47%
Days to Cover	6.79

Recent News

FDA Approves Checkpoint Therapeutics' Skin Cancer Drug One Year After Rejection

Checkpoint Therapeutics' Unloxcyt wins FDA approval for advanced cSCC, marking the company's entry into the U.S. market, valued over $1 billion annually.

Vandana Singh

US Stocks To Open Higher Ahead Of Fed's Decision This Week: Analyst Says 'Santa Comes Later In December'

U.S. stock futures were trading higher after the Nasdaq 100 extended its relentless climb last week, nearing the 22,000-point milestone.

Rishabh Mishra

Pinterest, Checkpoint Therapeutics And 2 Other Stocks Insiders Are Selling

The Nasdaq 100 closed higher by around 300 points on Friday. Investors, meanwhile, focused on some notable insider trades.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	7.09K / 1.30M
Day Range	- - -
52 Wk Range	1.38 - 4.50
Market Cap	$177.26M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	14.47%
Days to Cover	6.79

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Checkpoint Therapeutics (CKPT) stock?

You can purchase shares of Checkpoint Therapeutics (NASDAQ:CKPT) through any online brokerage.

View our list of the best stock brokerages

Who are Checkpoint Therapeutics (CKPT) competitors?

Other companies in Checkpoint Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), Invizyne Technologies (NASDAQ:IZTC), Fate Therapeutics (NASDAQ:FATE) and Tevogen Bio Holdings (NASDAQ:TVGN).

What is the forecast, or price target, for Checkpoint Therapeutics (CKPT) stock?

Checkpoint Therapeutics has a consensus price target of $26.83.

What is the current price for Checkpoint Therapeutics (CKPT)?

The stock price for Checkpoint Therapeutics (NASDAQ: CKPT) is $3.63 last updated December 23, 2024 at 4:56 AM EST.

Does Checkpoint Therapeutics (CKPT) pay a dividend?

There are no upcoming dividends for Checkpoint Therapeutics.

When is Checkpoint Therapeutics (NASDAQ:CKPT) reporting earnings?

Checkpoint Therapeutics’s Q4 earnings are confirmed for Friday, March 21, 2025.

Is Checkpoint Therapeutics (CKPT) going to split?

There is no upcoming split for Checkpoint Therapeutics.

What sector and industry does Checkpoint Therapeutics (CKPT) operate in?

Checkpoint Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Checkpoint Therapeutics

Checkpoint Therapeutics (CKPT) Forecast